Director SCHECHTER JONATHAN 🟡 adjusted position in 145.7K shares (1 derivative) of PharmaCyte Biotech, Inc. (PMCB) at $1.22 Transaction Date: Apr 25, 2025 | Filing ID: 009113
Director Abecassis Michael M 🟡 adjusted position in 83.9K shares (1 derivative) of PharmaCyte Biotech, Inc. (PMCB) at $1.22 Transaction Date: Apr 25, 2025 | Filing ID: 009112